MICHELLE OVANDO: Open Payments
NPI 1760676969 · TINLEY PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,677 in 69 payments from 16 companies in 2025. Trend: 2023 $1,270 · 2024 $1,418 · 2025 $1,677
Food & beverage: $1,577Education: $100
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 9 | $274 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $223 |
| ABBVIE INC. | 12 | $219 |
| Novartis Pharmaceuticals Corporation | 5 | $164 |
| GENZYME CORPORATION | 4 | $163 |
| UCB, Inc. | 5 | $126 |
| Amgen Inc. | 4 | $105 |
| Lilly USA, LLC | 4 | $90 |
| Arcutis Biotherapeutics, Inc. | 4 | $68 |
| LEO Pharma Inc. | 3 | $53 |
Products named: DUPIXENT, Bimzelx, RINVOQ, OTEZLA, SKYRIZI, EBGLYSS, LIBTAYO, Zoryve.
Industry payments across IL — which companies pay providers there.
